2019
DOI: 10.1016/j.jval.2019.04.086
|View full text |Cite
|
Sign up to set email alerts
|

PBI3 A REVIEW ON PEARLS & PITFALLS OF AUTOLOGOUS BONE MARROW DERIVED MESENCHYMAL STROMAL/STEM CELL THERAPY IN END STAGE LUNG DISEASE; LONGITUDINAL ASSESSMENT OF HEALTH RELATED QUALITY OF LIFE IN THESE PATIENTS

Abstract: Objectives: Lung diseases contribute to a major cause of morbidity & mortality worldwide in current scenario. Though invasive & expensive, lung transplantation (single/double) is a definitive treatment option for End-Stage-Lung-Disease (ESLD) patients who show survival of more than 80% up to year which then drops down to 50% after 3 years. Despite advancements in surgical techniques, complications are inevitable with scarcity of donor lung availability, lung preservation, immunosuppression, management of ische… Show more

Help me understand this report

This publication either has no citations yet, or we are still processing them

Set email alert for when this publication receives citations?

See others like this or search for similar articles